Home » Topics » Regulatory » EMA

EMA
RSS

EMA approves RoActemra for polyarticular juvenile idiopathic arthritis

June 10, 2013

Bavarian Nordic's smallpox vaccine receives positive opinion from CHMP

June 4, 2013

Lucentis receives positive CHMP opinion in myopic choroidal neovascularization

June 4, 2013

European CHMP recommends approval of Teva's Lonquex

June 4, 2013

CHMP recommends European approval of once-weekly somatropin

June 3, 2013

CMDh endorses EMA committee's recommendation on benefit/risk profile of Diane-35

June 3, 2013

European CHMP recommends approval of Lojuxta

June 3, 2013

European CHMP recommends approval of pomalidomide for rrMM

June 3, 2013

BioMarin's applications for Vimizim accepted by both FDA and EMA

May 31, 2013

EMA grants orphan drug designation to Sucampo's retinitis pigmentosa therapeutic

May 30, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...